Kevin P. Foley

8.9k total citations · 2 hit papers
77 papers, 5.0k citations indexed

About

Kevin P. Foley is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Kevin P. Foley has authored 77 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 15 papers in Physiology and 14 papers in Epidemiology. Recurrent topics in Kevin P. Foley's work include Gut microbiota and health (11 papers), Heat shock proteins research (11 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Kevin P. Foley is often cited by papers focused on Gut microbiota and health (11 papers), Heat shock proteins research (11 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Kevin P. Foley collaborates with scholars based in United States, Canada and France. Kevin P. Foley's co-authors include Amira Klip, Jonathan D. Schertzer, James Douglas Engel, Harald S. Haugen, Jane A. Gross, Sherri Mudri, Stacey R. Dillon, Janet Johnston, Margaret Moore and Mark Leonard and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kevin P. Foley

74 papers receiving 4.9k citations

Hit Papers

TACI and BCMA are receptors for a TNF homologue implicate... 2000 2026 2008 2017 2000 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin P. Foley United States 37 2.4k 1.7k 738 487 467 77 5.0k
Hermann‐Josef Gröne Germany 44 2.6k 1.1× 1.5k 0.9× 575 0.8× 366 0.8× 790 1.7× 125 6.6k
Saleh Ibrahim Germany 41 2.7k 1.1× 1.6k 1.0× 597 0.8× 964 2.0× 783 1.7× 202 5.9k
David R. Booth Australia 41 3.8k 1.6× 1.4k 0.8× 1.1k 1.4× 550 1.1× 684 1.5× 115 6.1k
Carlos A. Casiano United States 41 3.6k 1.5× 1.6k 0.9× 610 0.8× 631 1.3× 842 1.8× 101 6.5k
Lloyd B. Klickstein United States 43 1.5k 0.6× 2.7k 1.6× 882 1.2× 313 0.6× 684 1.5× 88 5.8k
Tomoko Takano Canada 42 2.4k 1.0× 1.4k 0.8× 486 0.7× 177 0.4× 444 1.0× 145 6.0k
Martin P. Playford United States 32 1.5k 0.6× 1.2k 0.7× 293 0.4× 491 1.0× 366 0.8× 102 3.8k
Christian P. Sommerhoff Germany 39 1.9k 0.8× 1.1k 0.6× 602 0.8× 268 0.6× 421 0.9× 97 4.3k
Hirotoshi Nakamura Japan 41 1.6k 0.6× 962 0.6× 923 1.3× 367 0.8× 636 1.4× 246 6.2k
Carlo Pucillo Italy 37 1.2k 0.5× 2.6k 1.5× 800 1.1× 386 0.8× 493 1.1× 112 4.4k

Countries citing papers authored by Kevin P. Foley

Since Specialization
Citations

This map shows the geographic impact of Kevin P. Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Foley more than expected).

Fields of papers citing papers by Kevin P. Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Foley. The network helps show where Kevin P. Foley may publish in the future.

Co-authorship network of co-authors of Kevin P. Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Foley. A scholar is included among the top collaborators of Kevin P. Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Foley. Kevin P. Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yaya, Jinhua Li, Christian Ascoli, et al.. (2025). Chaperone directed heterobifunctional molecules circumvent KRASG12C inhibitor resistance. Cancer Letters. 622. 217691–217691.
2.
DeJong, Erica N., Daniel M. Marko, Kevin P. Foley, et al.. (2025). Microbiota protect against frailty and loss of skeletal muscle, and maintain inflammatory tone during aging in mice. American Journal of Physiology-Cell Physiology. 328(3). C887–C894. 2 indexed citations
3.
Anhê, Fernando F., Soumaya Zlitni, Song‐Yang Zhang, et al.. (2022). Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut. 72(3). 460–471. 43 indexed citations
4.
5.
Duggan, Brittany M., Joseph F. Cavallari, Kevin P. Foley, Nicole G. Barra, & Jonathan D. Schertzer. (2020). RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice. Endocrinology. 161(8). 16 indexed citations
6.
Alfano, Danielle N., Linda R. Klei, Peter J. Gough, et al.. (2020). MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial Cells. The Journal of Immunology. 204(9). 2337–2348. 12 indexed citations
7.
Petrick, Heather L., Kevin P. Foley, Soumaya Zlitni, et al.. (2020). Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not Required. Function. 1(2). zqaa013–zqaa013. 14 indexed citations
8.
Yu, Jong W., Sandy Hoffman, Allison M. Beal, et al.. (2015). MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses. PLoS ONE. 10(5). e0127083–e0127083. 66 indexed citations
9.
Cavallari, Joseph F., Morgan D. Fullerton, Emmanuel Denou, et al.. (2014). 22. Cytokine. 70(1). 33–33. 1 indexed citations
10.
Shimamura, Takeshi, Samanthi A. Perera, Kevin P. Foley, et al.. (2012). Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(18). 4973–4985. 131 indexed citations
11.
Ying, Weiwen, Zhenjian Du, Lijun Sun, et al.. (2011). Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy. Molecular Cancer Therapeutics. 11(2). 475–484. 181 indexed citations
12.
Bear, Misty D., et al.. (2008). The novel HSP90 inhibitor STA-9090 exhibits activity against Kit dependent and independent malignant mast cell tumors.. Cancer Research. 68. 5638–5638. 2 indexed citations
13.
Foley, Kevin P., John Bertin, Amy Hutchings, et al.. (2007). The oxidative stress inducer STA-4783 enhances the in vivo efficacy of multiple anti-cancer therapies in mouse tumor models. Molecular Cancer Therapeutics. 6. 4 indexed citations
14.
Kirshner, Jessica R., Zhenjian Du, Jane Kepros, et al.. (2007). STA-4783 induces apoptosis and enhances the anticancer activity of paclitaxel through induction of oxidative stress. Molecular Cancer Therapeutics. 6. 1 indexed citations
15.
Foley, Kevin P.. (2003). Geriatric Medicine: An Evidence-Based Approach, 4th Ed.. 6(2). 139–139. 22 indexed citations
16.
Foley, Kevin P. & Robert N. Eisenman. (1999). Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1423(3). M37–M47. 46 indexed citations
17.
McArthur, Grant A., Carol D. Laherty, Peter J. Hurlin, et al.. (1998). The Mad Protein Family Links Transcriptional Repression to Cell Differentiation. Cold Spring Harbor Symposia on Quantitative Biology. 63(0). 423–434. 49 indexed citations
18.
Foley, Kevin P.. (1998). Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. The EMBO Journal. 17(3). 774–785. 114 indexed citations
19.
Quéva, Christophe, Peter J. Hurlin, Kevin P. Foley, & Robert N. Eisenman. (1998). Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene. 16(8). 967–977. 109 indexed citations
20.
Foley, Kevin P., Mark Leonard, & James Douglas Engel. (1993). Quantitation of RNA using the polymerase chain reaction. Trends in Genetics. 9(11). 380–385. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026